T. Rowe Price Associates’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Buy
251,209
+39,376
+19% +$387K ﹤0.01% 1754
2025
Q4
$1.48M Buy
211,833
+14,211
+7% +$89.4K ﹤0.01% 1902
2025
Q3
$1.13M Buy
197,622
+19,572
+11% +$104K ﹤0.01% 2003
2025
Q2
$852K Buy
178,050
+27,129
+18% +$156K ﹤0.01% 2060
2025
Q1
$1.31M Buy
150,921
+11,548
+8% +$121K ﹤0.01% 1816
2024
Q4
$1.69M Buy
139,373
+15,048
+12% +$211K ﹤0.01% 1725
2024
Q3
$2.09M Sell
124,325
-8,871
-7% -$146K ﹤0.01% 1619
2024
Q2
$2.08M Buy
133,196
+7,101
+6% +$98.7K ﹤0.01% 1535
2024
Q1
$1.99M Buy
126,095
+7,946
+7% +$133K ﹤0.01% 1568
2023
Q4
$2.38M Buy
118,149
+4,848
+4% +$82.1K ﹤0.01% 1444
2023
Q3
$2.1M Buy
113,301
+4,097
+4% +$89.2K ﹤0.01% 1440
2023
Q2
$2.38M Buy
109,204
+5,417
+5% +$97.9K ﹤0.01% 1421
2023
Q1
$1.92M Buy
103,787
+9,476
+10% +$178K ﹤0.01% 1471
2022
Q4
$1.44M Buy
94,311
+37,886
+67% +$540K ﹤0.01% 1595
2022
Q3
$789K Buy
56,425
+16,262
+40% +$327K ﹤0.01% 1879
2022
Q2
$968K Buy
40,163
+759
+2% +$20.4K ﹤0.01% 1910
2022
Q1
$1.22M Buy
39,404
+2,962
+8% +$106K ﹤0.01% 1904
2021
Q4
$1.66M Sell
36,442
-2,392
-6% -$102K ﹤0.01% 1792
2021
Q3
$1.69M Sell
38,834
-560
-1% -$24.4K ﹤0.01% 1803
2021
Q2
$1.81M Sell
39,394
-3,758
-9% -$174K ﹤0.01% 1782
2021
Q1
$1.92M Sell
43,152
-5,482
-11% -$230K ﹤0.01% 1742
2020
Q4
$1.93M Sell
48,634
-542
-1% -$20.1K ﹤0.01% 1648
2020
Q3
$1.92M Sell
49,176
-2,042
-4% -$78.2K ﹤0.01% 1560
2020
Q2
$1.99M Sell
51,218
-2,012
-4% -$68K ﹤0.01% 1538
2020
Q1
$1.78M Buy
53,230
+5,330
+11% +$175K ﹤0.01% 1530
2019
Q4
$1.56M Buy
47,900
+9,066
+23% +$298K ﹤0.01% 1695
2019
Q3
$1.32M Buy
38,834
+484
+1% +$16.8K ﹤0.01% 1698
2019
Q2
$1.19M Buy
38,350
+280
+0.7% +$8.25K ﹤0.01% 1777
2019
Q1
$1.09M Buy
38,070
+850
+2% +$25.7K ﹤0.01% 1801
2018
Q4
$1.06M Buy
37,220
+4,690
+14% +$147K ﹤0.01% 1773
2018
Q3
$1.16M Buy
32,530
+352
+1% +$15K ﹤0.01% 1818
2018
Q2
$1.29M Buy
32,178
+120
+0.4% +$4.42K ﹤0.01% 1731
2018
Q1
$1.07M Buy
32,058
+210
+0.7% +$6.33K ﹤0.01% 1761
2017
Q4
$982K Sell
31,848
-27
-0.1% -$818 ﹤0.01% 1827
2017
Q3
$926K Hold
31,875
﹤0.01% 1844
2017
Q2
$826K Buy
31,875
+8
+0% +$192 ﹤0.01% 1863
2017
Q1
$783K Hold
31,867
﹤0.01% 1884
2016
Q4
$789K Buy
31,867
+267
+0.8% +$5.93K ﹤0.01% 1867
2016
Q3
$663K Sell
31,600
-3,200
-9% -$68.5K ﹤0.01% 1901
2016
Q2
$734K Sell
34,800
-7,200
-17% -$134K ﹤0.01% 1810
2016
Q1
$793K Buy
42,000
+6,667
+19% +$127K ﹤0.01% 1785
2015
Q4
$749K Buy
35,333
+266
+0.8% +$5.42K ﹤0.01% 1786
2015
Q3
$592K Buy
35,067
+4,800
+16% +$94.5K ﹤0.01% 1883
2015
Q2
$538K Hold
30,267
﹤0.01% 1966
2015
Q1
$530K Hold
30,267
﹤0.01% 1957
2014
Q4
$563K Sell
30,267
-4,266
-12% -$70.2K ﹤0.01% 1920
2014
Q3
$512K Hold
34,533
﹤0.01% 1926
2014
Q2
$524K Buy
34,533
+4,533
+15% +$67.3K ﹤0.01% 1935
2014
Q1
$506K Buy
30,000
+800
+3% +$13.1K ﹤0.01% 1915
2013
Q4
$500K Hold
29,200
﹤0.01% 1904
2013
Q3
$443K Hold
29,200
﹤0.01% 1933
2013
Q2
$406K Buy
+29,200
New +$385K ﹤0.01% 1948

Other funds holding NEOG

T. Rowe Price Associates's NEOG Position: Q1 2026 in Review

T. Rowe Price Associates increased its Neogen (NEOG) stake by 19% in Q1 2026, buying an estimated $387K and bringing the position to 251,209 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

T. Rowe Price Associates first reported a position in NEOG in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.38M in Q4 2023. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • T. Rowe Price Associates held 251,209 shares of Neogen worth $2.33M as of Q1 2026.
  • T. Rowe Price Associates bought 39,376 Neogen shares in Q1 2026, an estimated $387K.
  • Neogen made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1754 holding.
  • T. Rowe Price Associates first reported a position in Neogen in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Neogen position peaked at $2.38M in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.